Skip to main content
FinSpry Logo
FinSpry
MGNX logo
MGNX
(NASDAQ)
MacroGenics, Inc.
$3.07-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MacroGenics (MGNX) Stock Price & Financial Analysis

MacroGenics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.83 - $3.16
52-Week High$3.54
52-Week Low$0.99
Open$2.83
Volume713.33K
Average Volume (3M)713.33K
Market Cap193.89M
Shares Outstanding63.16M
Price to Sales (P/S)1.23
Price to Book (P/B)3.29
EV/EBITDA-2.67
Revenue (TTM)149.50M
Net Income (TTM)-74.62M
Free Cash Flow (TTM)-82.95M
EPS (TTM)$-1.18
Profit Margin-49.91%
Operating Margin-48.72%
Return on Equity (ROE)-134.23%
Debt to Equity1.23
50-Day MA$2.24
200-Day MA$1.75
52-Week Change137.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MacroGenics

What is the current stock price for MGNX?

As of the latest trading session, MGNX stock trades at $3.07. The 52-week range is $0.99–$3.54, with a day range of $2.83–$3.16.

What is the P/E ratio for MGNX?

The P/E ratio (Price-to-Earnings) for MGNX is shown in the Key Statistics section. This valuation metric helps compare MacroGenics, Inc. to industry peers.

Does MGNX pay dividends?

MacroGenics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MGNX?

Based on 1 analyst, the consensus for MGNX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MGNX?

MacroGenics's market capitalization is $193.9M, classifying it as a micro-cap company. MacroGenics operates in the Healthcare sector within the Biotechnology industry.